Two-year follow-up of the RAVEL study: A randomized study with the sirolimus-eluting Bx VELOCITY stent in the treatment of patients with denovo native coronary artery lesions
- 19 March 2003
- journal article
- abstracts
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (6) , 32
- https://doi.org/10.1016/s0735-1097(03)80139-0